Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
CRO plans to double its revenues to become the largest independent CRO in Central and Eastern Europe.
January 12, 2018
By: Tim Wright
Editor-in-Chief, Contract Pharma
Following the global trend of consolidating market positions of clinical research organizations (CROs), Optimapharm, a leading CRO in Southeastern Europe, acquired the Czech-based CRO MKS Research. By acquiring MKS Research, Optimapharm will enter the Czech market, and further strengthen its portfolio of clients in the pharmaceutical and biotech industries and its market position in Central Europe. The company says the acquisition is in line with its medium-term strategic objective of becoming the largest independent CRO in Central and Eastern Europe, with business operations across Europe and the U.S. “The clinical research market is experiencing a continued growth and we have the knowhow, references and strong financial position enabling us to lead the consolidation in the region,” said Gordana Greguric Cicak, chief executive officer, Optimapharm. “Moreover, our ambition is to double our revenues over the next three years, and continue acquiring good-quality companies such as MKS Research.” By consolidating MKS Research, Optimapharm will have a total of 120 full-time employees and annual revenues over €12 million. Optimapharm is headquartered in Zagreb, Croatia, and has offices in more than ten European countries. It covers markets with over 200 million people and has the expertise to conduct phase I – IV clinical research across Europe and through partners in the U.S. “We are becoming a part of a much larger company with structured operational support. This means that we will be better able to focus on projects and growth in the Czech and Slovak markets, while our employees will have more opportunities to develop their careers within an international group and work on more complex projects,” said Veronika Sebkova, executive director, MKS Research. The value of the global clinical research market has been growing in the last several years at annual rates of more than 10%. In 2016, it reached $31.4 billion. It is expected to reach $49.26 billion in the 2017-2021 period (New Market Research Report, December 2017). The biggest market is the U.S., accounting for 40% of the global market, with Europe being the second largest.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !